Sarcoptes Scabiei: Allergen Proteins and Dust Mite Cross-Reactivity
Sarcoptes scabiei causes scabies β a parasitic infestation, not a classic allergy β but it uniquely possesses six WHO/IUIS-characterized allergen proteins. Five cross-react with house dust mite allergens, causing false-positive HDM allergy testing. Only Sar s 14 (apolipoprotein) is scabies-specific with no HDM cross-reactivity, making it a breakthrough diagnostic candidate. Crusted scabies triggers massive IgE elevation. Treatment is antiparasitic, not immunotherapy.
Free Β· 5 min Β· Insurance accepted
Key facts
Sarcoptes scabiei has 6 WHO/IUIS-characterized allergen proteins (Sar s 1, 3, 8, 10, 11, 14) β the largest formal allergen designation for any parasitic mite species.
WHO/IUIS Allergen Nomenclature Sub-Committee, allergen.org, 2025
Five of the 6 Sar s allergens are homologous to house dust mite proteins β patients with a history of scabies may have false-positive HDM allergy testing due to cross-reactive IgE.
Sar s 14 (apolipoprotein) has no HDM homolog β it is the only scabies-specific marker, making it a diagnostic breakthrough candidate for distinguishing true HDM sensitization from cross-reactive scabies IgE.
WHO/IUIS Allergen Nomenclature Sub-Committee, allergen.org, 2025
Classic scabies involves only 10β15 mites on the body, yet the itch is intense because most of it is an immune response (IgE-mediated) to mite proteins β not direct mite feeding.
What Is Sarcoptes Scabiei and Why Does It Have Allergen Designations?
Sarcoptes scabiei is the obligate human skin parasite that causes scabies β one of the most common dermatological infestations worldwide, affecting an estimated 200 million people at any given time.
Female mites burrow 2-3 mm per day through the stratum corneum of human skin, laying 2-3 eggs daily during a 4-6 week lifecycle entirely within the human host. Classic scabies involves only 10-15 mites on the body, yet the itch is intense because most of it is an immune response to mite proteins β not to the mites themselves.
What makes S. scabiei scientifically distinctive among the parasitic mites in this batch is its formal allergen designation: the WHO/IUIS Allergen Nomenclature Sub-Committee has characterized six S. scabiei allergen proteins β Sar s 1, 3, 8, 10, 11, and 14. These are genuine allergens recognized by human IgE antibodies. Five of the six are homologous to house dust mite (Dermatophagoides) allergens, creating a clinically important diagnostic problem: patients with a history of scabies who are subsequently tested for dust mite allergy may have false-positive results due to cross-reactive IgE. Sar s 14, an apolipoprotein with no HDM equivalent, is the only scabies-specific marker β a potential breakthrough for distinguishing true HDM sensitization from cross-reactive scabies-derived IgE.
Symptoms of Scabies: The Immune Response, Not Mite Numbers
Recognizing symptoms early helps you get the right treatment faster.
Nocturnal pruritus
moderateIntense generalized itch worse at night β the most characteristic symptom, present in >95% of scabies cases. Reflects immune sensitization to mite proteins rather than mite numbers.
Burrows
mildThin, winding, grayish channels 2-15 mm long representing the female mite's tunnel in the stratum corneum β pathognomonic when identified, most visible in finger web spaces.
Papules and vesicles
mildSmall red papules and clear vesicles at burrow sites and elsewhere, representing the immune response β a mix of Type IV hypersensitivity-driven inflammation and occasional IgE-mediated reactions.
Nodules (post-scabietic nodules)
mildPersistent reddish-brown pruritic nodules appearing on genitalia, axillae, or buttocks after treatment β represent ongoing immune response to residual mite antigen, not active infestation; resolve over weeks to months.
Secondary bacterial infection
severeScratching introduces Staphylococcus aureus and Streptococcus pyogenes, causing impetigo; streptococcal superinfection can trigger post-streptococcal glomerulonephritis β a rare but serious complication.
Crusted (Norwegian) scabies
severeHyperkeratotic, crusted plaques covering large body areas with thousands to millions of mites; minimally pruritic but massively contagious. Requires urgent treatment with systemic ivermectin plus topical permethrin.
When to see a doctor
The cardinal symptom of scabies is intense, widespread pruritus that is classically worse at night β a reflection of enhanced immune activity and mite feeding behavior. On first infestation, itch begins 4-6 weeks after exposure when immune sensitization is established. On re-infestation, itch begins within hours due to established immune memory. The distribution of lesions is diagnostically helpful: scabies preferentially affects the web spaces between fingers, wrists, elbows, axillae, waistline, buttocks, genitalia, and (in young children) palms and soles. The face and scalp are typically spared in adults but can be involved in infants. Characteristic burrows β thin, irregular, grayish-white or skin-colored lines 2-15 mm long β represent the female mite's tunnel and are most easily seen in finger web spaces and on the wrist. Burrows are pathognomonic when present but may be obscured by secondary changes. Crusted (Norwegian) scabies presents dramatically differently: thick, crusted hyperkeratotic plaques covering large body areas, minimal pruritus despite thousands of mites. This form is not itchier than classic scabies β the reduced itch reflects the immunosuppression that permitted hyper-infestation. Seek immediate medical attention if you develop crusted or hyperkeratotic lesions, or if you have scabies symptoms and are immunosuppressed β crusted scabies is highly contagious and requires urgent treatment.
Scabies, IgE, and Asthma: An Uncommon Intersection
Sarcoptes scabiei has a complex relationship with asthma through its allergen cross-reactivity with house dust mites. In crusted scabies, the massive polyclonal IgE elevation (sometimes exceeding 10,000 IU/mL) can include IgE directed against Sar s 1 (cysteine protease, homologous to Der p 1) and Sar s 10 (tropomyosin, homologous to Der p 10). This cross-reactive IgE may theoretically sensitize the respiratory immune response broadly, but direct evidence linking scabies infestation to asthma development is limited. The more clinically important connection is diagnostic: a patient with concurrent asthma and positive HDM allergy testing who has a history of scabies may have false-positive HDM results driven by Sar s antibodies rather than true Dermatophagoides sensitization. Component-resolved diagnostics using Sar s 14 can resolve this ambiguity.
Complications of Scabies
Scabies complications range from secondary bacterial skin infection β the most common β to potentially severe systemic disease from untreated crusted scabies. The diagnostic complication of cross-reactive IgE confounding HDM allergy testing is a particularly relevant clinical concern in the allergology context.
Secondary bacterial infection
Staphylococcus aureus and Streptococcus pyogenes superinfection of excoriated scabies lesions can cause impetigo, cellulitis, and sepsis. Streptococcal infection may trigger post-streptococcal glomerulonephritis in children.
False-positive HDM allergy testing
Cross-reactive IgE to Sar s 1, 3, 8, 10, and 11 can produce false-positive results on standard house dust mite allergy panels β misleading clinicians into prescribing HDM immunotherapy for patients who do not have true HDM sensitization.
Crusted scabies in immunosuppressed patients
Failure to diagnose and treat scabies in immunosuppressed individuals leads to crusted scabies with thousands to millions of mites, extreme contagiousness, and systemic sepsis risk from skin barrier failure.
Post-scabietic nodules
Persistent pruritic nodules lasting weeks to months after successful treatment β not reinfestation, but ongoing immune reaction to residual mite antigen. Topical or intralesional corticosteroids provide relief.
Institutional outbreaks
A single unrecognized scabies case in a nursing home or healthcare facility can generate a large outbreak affecting many residents and staff before diagnosis, requiring coordinated mass treatment.
How Sarcoptes Scabiei Causes Disease and Why Its Allergens Matter
Scabies transmission requires prolonged direct skin-to-skin contact β typically 15-20 minutes of sustained contact with an infested person. Brief handshakes rarely transmit scabies. High-risk scenarios include sleeping in the same bed as an infested person, sexual contact, household contact with a family member who has scabies, and institutional settings (nursing homes, prisons, childcare facilities) where close and sustained contact is unavoidable. Crusted (Norwegian) scabies β a hyper-infested form with thousands to millions of mites β is highly contagious and can spread via contaminated surfaces or fomites.
Human scabies mite
Sarcoptes scabiei var. hominis
Dog mange mite (causes transient human 'animal scabies')
Sarcoptes scabiei var. canis
House dust mite (cross-reactive allergens)
Dermatophagoides pteronyssinus
American house dust mite (cross-reactive allergens)
Dermatophagoides farinae
How it works
Sarcoptes scabiei triggers a dual immune mechanism. The dominant response is Type IV (T-cell-mediated delayed hypersensitivity): CD4+ Th1 and Th2 cells recognize mite proteins after antigen-presenting cell processing, producing cytokines that recruit eosinophils, lymphocytes, and macrophages to the infestation site β causing the characteristic pruritic papules appearing 3-6 weeks after first exposure. The IgE component (Type I) is less prominent in classic scabies with 10-15 mites but becomes massive in crusted scabies where mite allergen load is orders of magnitude higher, driving polyclonal IgE elevation sometimes exceeding 10,000 IU/mL. Cross-reactive IgE to Sar s allergens can persist after mite clearance and cause positive results on subsequent HDM allergy testing.
The immune response to scabies has two distinct phases. On first infestation, the sensitization phase takes 4-6 weeks before symptoms develop β during this window, a person is infested and contagious but not yet itching. On re-infestation (after treatment and subsequent re-exposure), symptoms begin within hours because immune memory is already established. The itch of scabies reflects this immune sensitization: it is predominantly Type IV (delayed hypersensitivity) mediated by T lymphocytes recognizing mite proteins, with a superimposed IgE component that becomes prominent in crusted scabies where allergen load is massive.
The six Sar s allergens β cysteine protease (Sar s 1, homologous to Der p 1), serine protease (Sar s 3), glutathione S-transferase (Sar s 8, homologous to Der p 8), tropomyosin (Sar s 10, homologous to Der p 10), paramyosin (Sar s 11), and apolipoprotein (Sar s 14) β are present in mite body proteins, feces, and eggs, released continuously during the infestation.
Risk factors to watch for
Household or sexual contact with infested individual
The primary transmission route β sustained direct skin-to-skin contact of 15+ minutes transfers female mites between individuals. All household contacts of a scabies case require simultaneous treatment.
Immunosuppression
Immunosuppressed individuals (HIV, organ transplant recipients, corticosteroid users) are at risk for crusted scabies β the hyper-infested form with thousands to millions of mites and markedly elevated IgE.
Institutional living
Nursing homes, childcare facilities, prisons, and military barracks facilitate scabies outbreaks through close sustained contact between residents and staff.
Prior scabies sensitization
Previous scabies infestation results in immune sensitization β re-exposure causes rapid symptom onset and may leave cross-reactive IgE that complicates subsequent HDM allergy testing.
The Allergy Cascade
Exposure
Allergen contact
Detection
Immune recognition
IgE Response
Antibody production
Mast Cells
Histamine release
Symptoms
Allergic reaction
1.Exposure
Allergen contact
2.Detection
Immune recognition
3.IgE Response
Antibody production
4.Mast Cells
Histamine release
5.Symptoms
Allergic reaction
Diagnosing Scabies and the Cross-Reactive IgE Problem
Scabies diagnosis in clinical practice is primarily clinical β characteristic distribution of pruritic lesions, nocturnal itch, and compatible exposure history provide sufficient basis for empiric treatment in most cases. Dermoscopy (handheld microscope) can identify the 'delta sign' β the mite's front legs appearing as a dark triangular structure at the leading edge of a burrow β with 91% sensitivity in trained hands. Skin scraping with microscopic examination of material from burrow sites (potassium hydroxide preparation) confirms the diagnosis when positive, but has sensitivity of only 46-90% depending on technique and experience. The allergist-relevant diagnostic challenge arises when patients who have had scabies subsequently undergo allergy testing for suspected house dust mite allergy. Five of six Sar s allergens cross-react with HDM allergens, meaning a positive specific IgE result to Dermatophagoides in a patient with scabies history may represent Sar s-derived cross-reactive IgE rather than true HDM sensitization. Component-resolved diagnostics using Sar s 14 (the only scabies-specific marker without HDM homology) can resolve this: Sar s 14 positive + Der p 2 negative indicates scabies-derived IgE rather than genuine HDM sensitization. At-home allergy testing services like Curex offer panels covering 40+ environmental allergens including house dust mite components. Patients with scabies history should inform their allergist so that the cross-reactivity problem is accounted for in test interpretation.
Clinical Examination with Dermoscopy
A dermatologist or skilled clinician examines characteristic burrows and lesion distribution under dermoscopy, identifying the 'delta sign' (mite body at burrow tip) or 'jet with condensation trail' (mite + burrow) with >90% sensitivity when performed by experienced practitioners.
Skin Scraping with Microscopy
A scalpel blade scrapes material from the terminal end of a burrow; the material is placed on a slide, cleared with mineral oil or KOH, and examined under a light microscope for mites, eggs, and fecal pellets (scybala). Finding any of these confirms the diagnosis.
Sar s 14 Component-Resolved Diagnostics
Specific IgE measurement to Sar s 14 (apolipoprotein, scabies-specific allergen without HDM homology) distinguishes scabies-derived IgE from genuine HDM sensitization. Sar s 14-positive + Der p 2-negative indicates cross-reactive scabies IgE; Der p 2-positive regardless of Sar s 14 status indicates genuine HDM sensitization.
Test from home with Curex
Skip the clinic visit. Curex sends an at-home allergy test kit to your door, and a board-certified allergist reviews your results to build a personalized treatment plan.
Take the allergy quizTreating Scabies: Antiparasitic Medications, Not Allergy Therapy
See how different approaches stack up for managing your allergy symptoms long-term.
Scabies treatment is antiparasitic β the goal is eliminating the mite infestation, which also resolves the immune response. The IgE and T-cell sensitization established by the infestation wanes after mite clearance, though cross-reactive Sar s IgE may persist for months to years. All household contacts and sexual partners must be treated simultaneously, regardless of symptoms, to prevent reinfestation from asymptomatic carriers.
Post-treatment pruritus lasting 2-4 weeks is extremely common and does not indicate treatment failure β it reflects the immune response to residual mite antigen (proteins from killed mites) rather than active infestation.
Permethrin 5% Topical Cream
The first-line topical treatment for scabies. Applied to the entire body surface from neck to toes (including under fingernails) for 8-14 hours, then washed off. A second application 7-14 days later is recommended to cover any eggs that hatched after the first treatment.
Elimite (permethrin 5% cream), generic permethrin 5%
Meta-analyses show permethrin 5% achieves cure rates of 89-98% with two applications; superior to lindane and comparable to oral ivermectin
Oral Ivermectin
Single-dose oral ivermectin is highly effective and preferred for mass treatment in institutional outbreaks, crusted scabies, and patients unable to apply topical treatment correctly. A second dose at day 14 is recommended for classic scabies; crusted scabies requires multiple doses with concurrent topical permethrin.
Stromectol (ivermectin), generic ivermectin
Meta-analyses show ivermectin cure rates of 73-100%; particularly effective for crusted scabies and institutional outbreak control when topical compliance is difficult
Antihistamines for Itch
Oral antihistamines reduce pruritus during and after scabies treatment β particularly useful at night when itch peaks. They do not treat the infestation but significantly improve patient comfort and reduce secondary infection risk from scratching.
Benadryl (diphenhydramine), Zyrtec (cetirizine), Atarax (hydroxyzine β Rx)
Effective symptomatic itch relief; hydroxyzine has additional anxiolytic properties useful for severe nocturnal pruritus
Topical Corticosteroids for Post-Scabietic Itch
Mid-potency topical corticosteroids applied to persistent pruritic areas after confirmed scabies clearance reduce the immune-mediated post-treatment itch. Applied only after completing antiparasitic treatment β do NOT use during active infestation as they suppress the immune response needed to fight the mites.
Triamcinolone 0.1% cream (Rx), Mometasone 0.1% cream (Rx)
Effectively reduces post-treatment immune-mediated itch; intralesional triamcinolone for persistent nodules
Environmental Decontamination
Wash all clothing, bedding, and towels used in the previous 3 days at β₯60Β°C or dry on high heat for 20+ minutes. Items that cannot be laundered should be bagged for 3-4 days (mites die without a host within 2-3 days). Vacuum mattresses and upholstered furniture.
N/A
Eliminates environmental mites on fomites, preventing re-exposure after treatment; less critical for classic scabies (few mites) but essential for crusted scabies
| Feature | Traditional | Allergy Shots (SCIT) | Immunotherapy (SLIT)Recommended |
|---|---|---|---|
| Treats root cause | No | Yes | Yes |
| Long-lasting relief | No | Yes | Yes |
| At-home treatment | Yes | No | Yes |
| No office visits | Yes | No | Yes |
| Low side effects | Yes | Partial | Yes |
| Estimated cost | Partial | Partial | Yes |
Traditional
- NoTreats root cause
- NoLong-lasting relief
- YesAt-home treatment
- YesNo office visits
- YesLow side effects
- PartialEstimated cost
Allergy Shots (SCIT)
- YesTreats root cause
- YesLong-lasting relief
- NoAt-home treatment
- NoNo office visits
- PartialLow side effects
- PartialEstimated cost
Immunotherapy (SLIT)
Recommended- YesTreats root cause
- YesLong-lasting relief
- YesAt-home treatment
- YesNo office visits
- YesLow side effects
- YesEstimated cost
Immunotherapy and Scabies: When the IgE Is Real vs Cross-Reactive
Instead of masking symptoms, immunotherapy retrains your immune system.
Immunotherapy plays no role in treating scabies itself β antiparasitic medication clears the infestation and the immune response resolves in its aftermath. However, scabies creates a genuine immunotherapy decision problem: patients with scabies history who test positive for house dust mite IgE may or may not have true HDM sensitization warranting HDM immunotherapy. Five Sar s allergens are homologous to Dermatophagoides allergens (particularly Sar s 1 to Der p 1, Sar s 10 to Der p 10), so cross-reactive IgE from previous scabies can produce a positive HDM RAST or skin test in a patient with no true HDM-related respiratory disease. Starting HDM immunotherapy in such a patient would be inappropriate β they would be receiving treatment for a sensitivity that doesn't drive their clinical disease. The resolution lies in Sar s 14 component-resolved diagnostics: Sar s 14 is scabies-specific with no HDM homology. If a patient is Sar s 14-positive and Der p 2-negative on component testing, their HDM positivity reflects cross-reactive scabies antibodies rather than genuine HDM sensitization. For patients who are truly HDM-sensitized and also have scabies history, allergen-specific immunotherapy drops, offered by providers like Curex with plan-specific pricing (https://getcurex.com/learn/curex-pricing), remain clinically appropriate for the confirmed Dermatophagoides sensitization β but the diagnostic workup must first establish that the IgE is genuine. Once genuine HDM sensitization is confirmed, a real-world Curex study of 2,897 patients on at-home sublingual immunotherapy (Tharpe et al., peer-reviewed in Frontiers in Allergy, 2026) found clinically meaningful symptom improvement rose to 45% of patients by two years and quality-of-life improvement reached 90.7%, with adherence above 90% and no anaphylaxis reported.
Complete antiparasitic treatment
Eradicate the scabies infestation with permethrin 5% or ivermectin before any allergy evaluation β active infestation confounds all IgE testing results.
Wait 3-6 months post-clearance
Allow cross-reactive Sar s IgE to wane before performing allergy panel testing for HDM β immediate post-treatment testing will still reflect scabies-driven antibodies.
Component-resolved diagnostics
If HDM testing is positive in a patient with scabies history, request Sar s 14 and Der p 2 component testing to distinguish cross-reactive from genuine HDM sensitization.
Initiate immunotherapy only for confirmed sensitization
If Der p 2 is positive (indicating genuine HDM sensitization independent of Sar s cross-reactivity), discuss SCIT or custom SLIT drops with your allergist.
βODACTRA (HDM SLIT tablet) demonstrates 16-22% relative reduction in rhinitis scores vs placebo in pivotal trials; custom SLIT drops show smaller but meaningful benefit in European RCT evidenceβ
Treat your Sarcoptes Scabiei: Allergen Proteins and Dust Mite Cross-Reactivity allergy at the source
See if at-home sublingual allergy drops fit your allergies β a 2-minute quiz, designed by board-certified allergists, with no needles and no clinic visits.
- MD-ledBoard-certified allergists
- Plan-specificPricing Β· Confirm your quote
- 50K+Patients treated
- HSA/FSAEligible
Living Through Scabies: What to Expect
Scabies is one of the most intensely uncomfortable skin conditions, and the experience can be psychologically exhausting β particularly when diagnosis is delayed or when persistent post-treatment itch leads patients to believe they are still infested. Understanding the disease timeline helps: active infestation symptoms resolve within days of treatment, but post-treatment immune-mediated itch persists for 2-6 weeks in most patients. This is normal and does not indicate treatment failure. For patients with a history of scabies who are now concerned about house dust mite allergy, the most important step is communicating your scabies history to your allergist before any IgE testing. This allows appropriate test selection (including Sar s 14 component testing where available) and accurate interpretation of results.
Post-treatment itch is normal β not reinfestation
Pruritus lasting 2-6 weeks after successful scabies treatment reflects the immune system responding to dead mite proteins, not living mites. Antihistamines and topical corticosteroids provide comfort; a second treatment course is only warranted if new burrows or active lesions appear.
Scabies history changes your allergy workup
If you have had scabies and now suspect HDM allergy, tell your allergist. Cross-reactive Sar s IgE can mimic HDM sensitization on standard tests. Sar s 14 component testing distinguishes genuine from false-positive HDM results.
Treat your contacts β no exceptions
Scabies inevitably recurs if household contacts are not treated simultaneously. Convincing resistant household members to undergo treatment even without symptoms is essential β asymptomatic infested individuals are contagious throughout the 4-6 week sensitization window.
Is Scabies Seasonal?
Scabies is a year-round condition with no meaningful seasonal pattern in temperate climates. Institutional outbreaks can cluster at any time, and global scabies epidemiology shows no consistent seasonal peak in community transmission. Some studies from resource-limited tropical settings have suggested increased transmission during cooler or dry seasons when people sleep more closely together for warmth, but this is not a consistent finding across populations. From a clinical perspective, scabies should be considered regardless of time of year when the clinical presentation and exposure history are consistent.
January - December
high intensity
Preventing Scabies and Its Diagnostic Complications
Scabies prevention centers on avoiding prolonged skin-to-skin contact with infested individuals, prompt treatment of identified cases, and simultaneous treatment of all close contacts to break the transmission chain. In institutional settings (nursing homes, hospitals), early recognition and coordinated mass treatment is critical to preventing outbreaks.
Treat all household contacts simultaneously
When scabies is diagnosed in any household member, all individuals sharing the living space β including asymptomatic contacts β should be treated simultaneously to eliminate the reinfestation cycle.
Launder all bedding and clothing promptly
Wash all clothing worn and bedding used in the previous 72 hours at β₯60Β°C on the same day as antiparasitic treatment to eliminate environmental mites.
Inform sexual partners
Sexual partners from the previous 6 weeks should be notified and treated β scabies is effectively a sexually transmissible infection in many adults.
Alert allergists to scabies history
Inform any allergist performing IgE testing of past scabies infestations β this history is essential for correctly interpreting HDM allergy test results and avoiding inappropriate immunotherapy prescriptions.
Healthcare worker PPE in known cases
Healthcare workers caring for patients with crusted scabies should use full contact precautions β gloves, gown, mask β as crusted scabies is highly contagious through casual contact.
Prognosis: Scabies Is Curable, but Allergen Confusion Persists
Scabies is curable with appropriate antiparasitic treatment β permethrin 5% or oral ivermectin achieves clearance in 89-98% of cases with correct application and simultaneous contact treatment. Post-treatment itch resolves over weeks. Reinfestation from untreated contacts is the most common cause of apparent treatment failure. Cross-reactive Sar s IgE may persist in serum for months to years after mite clearance, potentially complicating subsequent HDM allergy testing during that window. Proactively communicating scabies history to allergists and, where available, using Sar s 14 component-resolved diagnostics ensures that any subsequent HDM allergy evaluation is correctly interpreted.
Key takeaways
Sarcoptes scabiei has six WHO/IUIS-characterized allergens β uniquely among parasitic mites in this batch β making it the only parasitic mite with a formal allergen designation
Five Sar s allergens cross-react with house dust mite proteins; Sar s 14 is scabies-specific and can distinguish genuine from cross-reactive HDM sensitization
Scabies is a parasitic infestation treated with antiparasitics (permethrin, ivermectin) β not allergen immunotherapy
Post-treatment itch lasting up to 6 weeks does not indicate treatment failure or reinfestation
Scabies-HDM allergy overlap is a real and under-recognized clinical problem β a patient with recent or past crusted scabies who tests positive on a standard dust mite panel may have HDM allergy, scabies-derived cross-reactive IgE, or both. Sar s 14 component testing, when available, is the tool that can distinguish these scenarios and prevent inappropriate immunotherapy prescription.
Frequently Asked Questions
Scabies is primarily a parasitic infestation β Sarcoptes scabiei is a living mite that burrows into and completes its lifecycle within human skin. However, uniquely among ectoparasites, it triggers a genuine IgE-mediated immune response through six WHO/IUIS-characterized allergen proteins. So while scabies is treated with antiparasitics rather than allergy medications, it occupies a clinical gray zone: more than an irritant bite reaction, less than a classic environmental allergy. The itch of scabies is largely immunological β driven by T-cell and mast cell responses to mite proteins β.
Medical References
- [1]WHO/IUIS Allergen Nomenclature Sub-Committee. Allergen Nomenclature Database. Available at: allergen.org. Accessed 2025.
- [2]Sporik R, Holgate ST, Platts-Mills TAE, Cogswell JJ. Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. N Engl J Med. 1990;323:502-507.
- [3]Arlian LG, Platts-Mills TAE. The biology of dust mites and the remediation of mite allergens in allergic disease. J Allergy Clin Immunol. 2001;107:S422-S429.
- [4]SΓ‘nchez-Borges M, FernΓ‘ndez-Caldas E, Thomas WR, et al. International consensus (ICON) on: clinical consequences of mite hypersensitivity, a global problem. World Allergy Organ J. 2017;10:14.
- [5]CDC. Scabies: Epidemiology and Risk Factors. Centers for Disease Control and Prevention. Available at: cdc.gov. Accessed 2025.
- [6]Mayo Clinic. Scabies: Diagnosis and Treatment. Mayo Clinic. Available at: mayoclinic.org. Accessed 2025.
- [7]Resch Y, Weghofer M, Seiberler S, et al. Molecular characterization of Der p 10: a diagnostic marker for broad sensitization in house dust mite allergy. Clin Exp Allergy. 2011;41:1468-1477.
- [8]Tharpe C, et al. Real-world outcomes of personalized sublingual immunotherapy for environmental allergies delivered through a telemedicine platform. Frontiers in Allergy. 2026;7:1865860.
- [9]Schaffer FM, Naples AR, Ebeling M, Hulsey TC, Garner LM. The safety of self-administered allergen immunotherapy during the buildup and maintenance phases. Int Forum Allergy Rhinol. 2015;5(2):149-156.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Ready to treat your Sarcoptes Scabiei: Allergen Proteins and Dust Mite Cross-Reactivity allergies for good?
Get a personalized treatment plan from board-certified allergists, delivered to your door.
Reviewed by board-certified allergists. Personalized treatment plans based on your at-home IgE test, not generic protocols.
Compare Curex plan pricingQuestions about Curex itself?
Straight answers about the company, the evidence, what patients report, and what it costs β including the parts that are not flattering.
